Latest News

ASCRS Run for Sight!

Posted on 18 May 2018

Dr Apel is an avid runner, passionate about eyes, and committed to ophthalmic education and research. When the opportunity presented to support a good cause, squeeze in another morning run, and spend three days liaising with fellow leading anterior segment physicians from around the world, Dr Apel just couldn’t pass it up. Dr Apel attended the American Society of Cataract and Refractive Surgery’s (ASCRS) Annual Meeting in Washington DC, USA this week. The conference brings together international Cornea and Refractive Surgery specialists to discuss the latest outcomes and advances in all things cornea and anterior eye related. Dr Andrew Apel…

Read More +

Australian Vision Convention

Posted on 9 April 2018

Over the weekend, the Australian Vision Convention was held in Brisbane.  This is a networking and continued professional development event held once a year for the Optometry Profession.  Dr Andrew Apel and one of our Clinical Optometrists, Jason Holland, were delighted to be asked to attend as speakers at the event. Dr Andrew Apel’s seminar topic was ‘Improving the Performance of the Cornea’, in particular discussing how to optimize long term vision outcomes after Corneal Graft Surgery.  DMEK corneal transplant surgery is quickly becoming the most preferable surgical approach for endothelial diseases, due to reduced rejection rates and better refractive…

Read More +

Clinical Optometry Team host dinner for local Brisbane Optometrists

Posted on 29 March 2018

The Eye Health Centre’s Clinical Optometrists hosted a ‘Clinical Discussion’ dinner event for inner city Brisbane Optometrists on Tuesday evening. The dinner was held at the esteemed Malt Dining in Brisbane CBD. The night involved great food and wine, and engaging discussion on the role of our clinical optometrists, and updates on the clinical services available at The Eye Health Centre. Topics discussed included the Keratoconus Care Clinic, Dry Eye Clinic, and Pre-Op assessments and Post-Op care for Cataract Surgery, Refractive Lens Exchange, Implantable Contact Lenses, Corneal Graft Surgery and Pterygium Surgery. Our Clinical Optometrists are highly skilled and expertly…

Read More +

World Glaucoma Week 11th-18th March

Posted on 11 March 2018

Today marks the start of World Glaucoma Week 2018! With as many as 50% of Australians with Glaucoma currently undiagnosed, Dr Andrew Apel and the team at The Eye Health Centre encourage you to have regular eye health checks to assess your optic nerve health, and screen for Glaucoma. The World Glaucoma Week campaign aims to raise awareness about Glaucoma, and more information can be found by clicking here; https://www.wgweek.net/about-world-glaucoma-week/ Dr Andrew Apel is leading the way in new surgical interventions for Glaucoma, utilising both the iStent® and CyPass® Micro Stent implants. These devices are used in minimally invasive surgery…

Read More +

Dr Andrew Apel Lectures at the 2018 Sydney DMEK Course

Posted on 27 February 2018

Dr Andrew Apel spent the weekend in Sydney, serving as a lecturer and instructor at the Sydney DMEK Course at Sight Foundation Clinical Skills Laboratory. DMEK is a corneal graft technique that replaces only the posterior cornea (Descemet’s Membrane and Endothelium), and is an anatomically correct way of replacing only the diseased endothelium of the cornea. There is less risk of donor rejection, and lower residual refractive error than with traditional full thickness corneal transplant technique. Dr Apel is a pioneer of DMEK surgery as a corneal transplant technique, having performed the procedure since 2009, and is highly regarded as…

Read More +

Medicare Approves Item Number for Corneal Collagen Cross Linking

Posted on 26 February 2018

Good news for patients with progressive Keratoconus and other types of Corneal Ectasia. Medicare has approved a new item number for the Corneal Collagen Crosslinking procedure as of 1st May, 2018. This is a safe technique, using Riboflavin (vitamin B2) and UVA light (365-370um) to stiffen and strengthen the cornea, and is the only evidenced method to halt progression of these potentially sight-threatening conditions. Until now, the procedure has been an entirely out-of-pocket expense for patients, making it an inaccessible option for some people.